1. Home
  2. AVO vs MPLT Comparison

AVO vs MPLT Comparison

Compare AVO & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$13.09

Market Cap

1.2B

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$36.70

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVO
MPLT
Founded
1983
2018
Country
United States
United States
Employees
N/A
133
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
AVO
MPLT
Price
$13.09
$36.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$17.00
$32.67
AVG Volume (30 Days)
1.5M
536.2K
Earning Date
06-04-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
1.92
N/A
EPS
N/A
N/A
Revenue
$1,391,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.68
N/A
52 Week Low
$10.07
$12.24
52 Week High
$15.53
$40.43

Technical Indicators

Market Signals
Indicator
AVO
MPLT
Relative Strength Index (RSI) 59.93 59.78
Support Level $13.03 $26.20
Resistance Level $14.28 N/A
Average True Range (ATR) 0.49 2.86
MACD 0.10 0.18
Stochastic Oscillator 67.99 67.55

Price Performance

Historical Comparison
AVO
MPLT

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: